Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides

被引:33
作者
Endo, Yoshio [1 ]
Obata, Tohru
Murata, Daigo
Ito, Mariho
Sakamoto, Kazuki
Fukushima, Masakazu
Yamasaki, Yasundo
Yamada, Yuji
Natsume, Nagato
Sasaki, Takuma
机构
[1] Kanazawa Univ, Dept Expt Therapeut, Inst Canc Res, Kanazawa, Ishikawa 9200934, Japan
[2] Kanazawa Univ, Dept Mol Virol & Oncol, Inst Canc Res, Kanazawa, Ishikawa 9200934, Japan
[3] Aichi Gakuin Univ, Lab Bioorgan Chem, Sch Pharm, Nagoya, Aichi 4648650, Japan
[4] Taiho Pharmaceut Co, Tokushima Res Ctr, Tokushima 7710194, Japan
[5] Taiho Pharmaceut Co, Hanno Res Ctr, Hanno, Saitama 3578527, Japan
[6] Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Surg 2, Nagoya, Aichi 4648650, Japan
关键词
D O I
10.1111/j.1349-7006.2007.00581.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Nucleoside transporters play an important role in the disposition of nucleosides and their analogs. To elucidate the relationship between chemosensitivity to antitumor nucleosides and the functional expression of equilibrative nucleoside transporters (ENT), we established stable cell lines of human fibrosarcoma HT-1080 and gastric carcinoma TMK-1 that constitutively overexpressed green fluorescent protein-tagged hENT1, hENT2, hENT3 and hENT4. Both hENT1 and hENT2 were predictably localized to the plasma membrane, whereas hENT3 and hENT4 were localized to the intracellular organelles. The chemosensitivity of TMK-1 cells expressing hENT1 and hENT2 to cytarabine and 1-(3-C-ethynyl-beta-d-ribopentofuranosyl) cytosine increased markedly in comparison to that of mock cells. However, no remarkable changes in sensitivity to antitumor nucleosides were observed in cell lines that expressed both hENT3 and hENT4. These data suggest that hENT3 and hENT4, which are mainly located in the intracellular organelles, are not prominent nucleoside transporters like hENT1 and hENT2, which are responsible for antitumor nucleoside uptake.
引用
收藏
页码:1633 / 1637
页数:5
相关论文
共 34 条
[1]
Determinants of sensitivity and resistance to gemcitabine: The roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer [J].
Achiwa, H ;
Oguri, T ;
Sato, S ;
Maeda, H ;
Niimi, T ;
Ueda, R .
CANCER SCIENCE, 2004, 95 (09) :753-757
[2]
1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (ECyd, tas-106)1:: Antitumor effect and mechanism of action [J].
Azuma, A ;
Matsuda, A ;
Sasaki, T ;
Fukushima, M .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) :609-619
[3]
Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes [J].
Baldwin, SA ;
Yao, SYM ;
Hyde, RJ ;
Ng, AML ;
Foppolo, S ;
Barnes, K ;
Ritzel, MWL ;
Cass, CE ;
Young, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (16) :15880-15887
[4]
The equilibrative nucleoside transporter family, SLC29 [J].
Baldwin, SA ;
Beal, PR ;
Yao, SYM ;
King, AE ;
Cass, CE ;
Young, JD .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2004, 447 (05) :735-743
[5]
Nucleoside transporters: molecular biology and implications for therapeutic development [J].
Baldwin, SA ;
Mackay, JR ;
Cass, CE ;
Young, JD .
MOLECULAR MEDICINE TODAY, 1999, 5 (05) :216-224
[6]
Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH [J].
Barnes, Kay ;
Dobrzynski, Halina ;
Foppolo, Sophie ;
Beal, Paul R. ;
Ismat, Fouzia ;
Scullion, Elspeth R. ;
Sun, Lijie ;
Tellez, James ;
Ritzel, Mabel W. L. ;
Claycomb, William C. ;
Cass, Carol E. ;
Young, James D. ;
Billeter-Clark, Rudi ;
Boyett, Mark R. ;
Baldwin, Stephen A. .
CIRCULATION RESEARCH, 2006, 99 (05) :510-519
[7]
BHALLA K, 1984, CANCER RES, V44, P5029
[8]
CARMICHAEL J, 1987, CANCER RES, V47, P936
[9]
Cass C E, 1999, Pharm Biotechnol, V12, P313
[10]
Identification and characterization of a novel monoamine transporter in the human brain [J].
Engel, K ;
Zhou, MY ;
Wang, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (48) :50042-50049